SUMMARY ANSWER: Suppression of COUP-TFII by hypoxia stimulates angiogenesis through induction of angiogenin (ANG).
Introduction
Endometriosis, characterized by the presence of endometrial tissues outside the uterine cavity, is one of the most common gynecological disorders. Approximately 10% of women of reproductive age world-wide are affected (Acien and Velasco, 2013) . Women with endometriosis often encounter symptoms such as chronic pelvic pain, dysmenorrhea, dyspareunia and infertility, which greatly reduce the quality of life . Surgical resection and hormonal treatment are two options for endometriosis treatment; however, many patients suffer from high recurrence rate and severe adverse effects (Cheong et al., 2008) . Up to now, there is no effective therapeutic regimen to cure endometriosis or to prevent it from recurrence. Thus, more efforts are needed to investigate the underlying mechanisms of endometriotic pathogenesis in order to develop better therapeutic strategies.
The etiology of endometriosis is multifactorial and complicated. Following the theory of retrograde menstruation (Sampson, 1927) , shed endometrial tissues encounter stressful challenges, such as nutrient and oxygen deficiencies (Wu et al. 2007a (Wu et al. , 2007b due to lack of blood supply either during retrograde menstruation or before blood vessel infiltration. It is well accepted that establishment of new blood vessels, known as angiogenesis, is essential for implantation and maintenance of shed endometrial tissues (Laschke and Menger, 2012) . For example, it has been noted that ectopic endometriotic lesions are surrounded by peritoneal blood vessels under direct inspection in laparoscopy (Nieminen, 1962) and the sizes of endometrial grafts are reduced by treatment with blockers of angiogenic factors in an animal model (Laschke et al., 2006) . These observations indicate that establishment of neovascular networks is critical for the development of endometriosis.
Hypoxia, a condition with an insufficient concentration of oxygen, plays crucial roles in the pathogenesis of endometriosis (Hsiao et al., 2015) . We have demonstrated that hypoxia-inducible factor-1α (HIF-1α), a master transcription factor for hypoxic response, is upregulated in ectopic endometriotic tissues (Wu et al. 2007a (Wu et al. , 2007b . Elevation of HIF-1α causes aberrant expression of its target genes, which exert critical biological processes to promote the progression of endometriosis (Hsiao et al., 2015) . For instance, suppression of dual-specific phosphatase 2 by HIF-1α leads to the overexpression of cyclo-oxygenase 2 (COX-2) (Wu et al., 2011; Lin et al., 2012) , which ultimately contributes to an increase in steroidogenesis (Attar et al., 2009) , antiapoptosis (Chuang et al., 2006) and immune suppression Wu et al., 2005 Wu et al., , 2013 . A growing body of evidence revealed that hypoxia also regulates angiogenesis in endometriosis by inducing the expression of angiogenic factors, such as vascular endothelial growth factors (VEGFs), leptin and interleukin-8 (Becker et al., 2008; Styer et al., 2008; Hsiao et al., 2014) . However, blocking the signaling pathways of these angiogenic factors only resulted in partial inhibition of angiogenesis, suggesting other unidentified angiogenic factors may exist.
Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII, also known as nuclear receptor subfamily 2 group F member 2, NR2F2) is an orphan nuclear receptor that regulates many physiological and pathological processes (Lin et al., 2011b) . In general, COUP-TFII plays an important role in angiogenesis. Targeted deletion of the COUP-TFII gene results in embryonic lethality with defects in angiogenesis (Pereira et al., 1999) . However, recent data demonstrated that COUP-TFII levels are downregulated in endometriotic tissue, which contributes to aberrant expression of COX-2, steroidogenic acute regulatory protein (StAR) and aromatase (Zeitoun et al., 1999; Attar et al., 2009; Lin et al., 2014) . Since COUP-TFII is a versatile transcription factor, we aim to further characterize the pathological role of COUP-TFII in endometriosis and to investigate whether hypoxia is a driving force for the loss of COUP-TFII in endometriotic cells.
Materials and Methods

Clinical samples
Eutopic endometrial and endometriotic tissues from patients of reproductive age were collected during laparoscopic or gynecological operations at the National Cheng Kung University Hospital. Overall, 27 patients of reproductive age with endometriosis and 11 without endometriosis were recruited in this study (Supplementary Table S1 ). All patients did not receive any hormonal treatment within 6 months before the surgery. The stage of endometriosis was classified according to the revised American Society for Reproductive Medicine (1997) . This study was approved by the Institutional Review Board at the National Cheng Kung University Medical Center and written informed consent was obtained from each patient.
Isolation and treatment of primary endometrial and endometriotic stromal cells
The procedure for isolation of endometrial stromal cells from patients with endometriosis was described previously (Tsai et al., 2001) . Usually, primary endometrial stromal cells between passage 3 and passage 6 were used in order to obtain enough cells for subsequent experiments. Normal eutopic endometrial and ectopic endometriotic stromal cells were maintained in 10-cm dishes with DMEM/F-12 containing 10% fetal bovine serum (FBS) in a humidified atmosphere of 5% CO 2 at 37°C. After serum starvation for 16 h, cells were treated with hypoxia (1% O 2 ) or normoxia (21% O 2 ) for 48 h. For hypoxia-mimetic treatment, cells were treated with desferroxamine (DFO, 0, 0.1, 1 mM) or dimethyloxaloylglycine (DMOG, 0, 0.5, 1 mM) to inhibit prolyl hydroxylase activity and thus cause HIF-1α accumulation under normoxia for 48 h. For the HIF-1α overexpression assay, stromal cells were transiently transfected with oxygen-insensitive HIF-1α (P402A/P564A) cDNA under normoxic condition, as previously described (Lin et al., 2011a) .
RNA isolation and quantitative RT-PCR
Total RNA isolation was performed according to the manufacturer's instructions (TRIsure; Bioline USA Inc., Taunton, MA, USA). Levels of mRNAs of interest were quantified after amplification with specific primers (Supplementary Table S2 ) and SYBR green-based quantitative PCR using Applied Biosystems StepOne Plus TM Real-time PCR system (Foster City, CA, USA).
Microarray analysis
Human endometrial stromal cells from three patients with endometriosis (one in secretory and two in proliferative phase) were transfected with either control siRNA oligonucleotide or oligonucleotides against COUP-TFII for 48 h, and total RNA was harvested and processed for microarray analysis using Affymetrix human U133 plus 2.0 array (Santa Clara, CA, USA) according to manufacturer's instructions in National Yang-Ming University VYM Genome Research Center. The signals were acquired by using a GeneChip ® GeneArray Scanner 3000 (Santa Clara, CA, USA). The results were corrected using RMA (Robust Multi-Array Average) among different batches of experiments, followed by quantile normalization using Partek Genomics Suite (Partek Inc., St. Louis, MO, USA). Those genes with more than 1.5-fold change and with a P-value < 0.05 were considered to show differential expression. The raw data were submitted to Gene Expression Omnibus (GSE107469).
Western blot analysis
Total proteins (15-30 μg) were analyzed following the standard procedures routinely used in our laboratory (Hsiao et al., 2017) . Briefly, protein samples prepared in radio-immunoprecipitation assay lysis buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS) and 150 mM NaCl, 50 mM TrisCl) containing protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 1 μg/ml aprotinin and 1 μg/ml pepstatin A) and phosphatase inhibitors (1 mM NaF and 1 mM Na 3 VO 4 ) were separated by running on a SDS-polyacrylamide gel electrophoresis. After being transferred onto a polyvinylidene fluoride membrane (Millipore Corp., Bedford, MA, USA), the membrane was blocked with 5% non-fat milk in PBST (PBS with 0.05% Tween-20) at room temperature for 1 hour, followed by incubation with primary antibody prepared in PBST at 4°C Table S2 ). The potential transcription factor binding sites on the ANG promoter were analyzed by using our bioinformatics platform, The Binding Element Searching Tool (The BEST, http://thebest.binfo.ncku.edu.tw/thebest/). Site-directed mutagenesis of putative CBE constructs was generated by using PCR amplification. The COUP-TFII promoter-driven luciferase activity was assayed using a reporter assay system, and a cytomegalovirus promoterdriven β-galactosidase plasmid was used as an internal control as described previously . A final concentration of 20 nM siRNA against COUP-TFII or control siRNAs was used for transfection (Supplementary Table S3 ). The expression constructs for COUP-TFII and HIF-1α were described in previous studies (Lin et al., 2011a . Briefly, 2 μg of empty vectors or COUP-TFII cDNA plasmids were transfected into ectopic endometriotic stromal cells or eutopic endometrial stromal cells isolated from patients with endometriosis and incubated for 48 h. Cells were then harvested for detecting ANG or subjected to normoxia/hypoxia treatment for another 24 h.
Chromatin immunoprecipitation assay
The procedures for the chromatin immunoprecipitation (ChIP) assay, with modifications, were described previously (Hsiao et al., 2014) . Briefly, 1% formaldehyde was used to crosslink DNA and COUP-TFII for 10 min at room temperature. Endometrial stromal cells were harvested and sonicated to generate DNA fragments (200-500 bp average size). The COUP-TFII antibody, as mentioned above, was used to immunoprecipitate the COUP-TFII/DNA complexes. The COUP-TFII binding DNA fragments were isolated and amplified by specific primers (Supplementary Table S2 ) after reversing crosslinks.
In vitro tube formation assay
Primary human umbilical vein endothelial cells (HUVECs) were maintained in the growth medium (1:3 ratio of M199/20% FBS to EGM-2; Lonza, EGM-2 BulletKit CC-3156 & CC-4176; Walkersville, MD, USA) at 37°C in a 5% CO 2 incubator until 80% confluence was reached. Each well of μ-slide (ibidi, Martinsried, Germany. Cat#: 81506) was coated with 10 μl of Matrigel TM (BD Biosciences, Franklin Lakes, NJ, USA. 354230); then 1 × 10 4 HUVECs were seeded evenly. Conditioned media collected from primary cultures of endometrial stromal cells with different treatments were used to treat HUVECs. Bright-field images were acquired by using Nikon ECLIPSE Ti inverted microscope integrated with NIS-Elements BR 3.0 (Tokyo, Japan). The characteristic patterns of tube formation networks were analyzed using Wimasis Image analysis system (Thistle Scientific Co, Glasgow, UK).
Statistical analysis
Data were expressed as mean ± standard error of the mean (SEM). Student's t test was performed for comparison between two groups. For three or more groups, differences among groups were determined by one-way ANOVA followed by Tukey's multiple test using GraphPad Prism 5.0 (GraphPad Software, Inc., La Jolla, CA, USA). Statistical significance was set at P < 0.05.
Results
Expression of COUP-TFII is downregulated by hypoxia
Our previous data showed that expression of COUP-TFII is downregulated in ectopic endometriotic stromal cells . Since ectopic endometriotic cells suffered from hypoxic stress (Wu et al. 2007a (Wu et al. , 2007b , we tested whether low oxygen conditions would affect COUP-TFII level to de-repress critical genes for cell survival. Herein, we discovered that hypoxia suppressed COUP-TFII but not COUP-TFI mRNA (Fig. 1A) . Western blot data showed that the protein level of COUP-TFII was also decreased under hypoxia (Fig. 1B) . Treatment with DFO and DMOG, two hypoxia-mimetic compounds that cause HIF-1α accumulation under normoxia, also significantly reduced COUP-TFII mRNA expression level and protein in a dose-dependent manner ( Fig. 1C and D) . In addition, forced-expression of oxygen insensitive HIF-1α, which cannot be degraded due to the substitution of two proline residues in the oxygen dependent degradation domain with alanine, significantly suppressed COUP-TFII expression (Fig. 1E ). Taken together, these results demonstrated that hypoxia is a driving force to inhibit COUP-TFII expression through a HIF-1α dependent manner.
Hypoxia-suppressed COUP-TFII promotes angiogenic capacity
To investigate the plausible molecular changes involved in COUP-TFII downregulation, we performed microarray hybridization and bioinformatic analysis in COUP-TFII-knocked down endometrial stromal cells.
Results showed several angiogenesis-related genes, such as ANG and VEGF-C, were enriched in COUP-TFII knockdown stromal cells ( Fig.  2A) . To verify this finding, conditioned media derived from COUP-TFII knocked down stromal cells were collected and used to treat HUVECs. HUVECs treated with conditioned media collected from endometrial stromal cells with COUP-TFII knockdown formed more tube-like structures than those treated with conditioned media from control siRNA-treated stromal cells (Fig. 2B ). Since expression of COUP-TFII was suppressed by hypoxia, we next tested whether a similar effect would also be observed in hypoxia-treated endometrial stromal cells. As shown in Fig. 2C , treatment with conditioned media derived from hypoxia-treated endometrial stromal cells stimulated more tube formation compared to the normoxia-treated group (Fig. 2C) . To identify novel angiogenic factors regulated by COUP-TFII, we employed bioinformatic analysis of our microarray data and noticed some angiogenic factors, such as ANG and VEGF-C, were upregulated by knockdown of COUP-TFII. Since ANG has been shown as a potent angiogenic factor in colon cancer , it may be a potential candidate gene. To verify that ANG is indeed regulated by COUP-TFII, eutopic endometrial stromal cells, which have higher level of COUP-TFII compared to the ectopic counterparts, were transfected with siRNA against COUP-TFII and results showed that knockdown of COUP-TFII increased ANG mRNA and protein in endometrial stromal cells ( Fig. 2D and E) . In contrast, overexpression of COUP-TFII in ectopic endometriotic stromal cells, which have lower level of COUP-TFII, suppressed ANG expression (Fig. 2F) .
To elucidate the underlying mechanism of COUP-TFII-suppressed ANG expression, we analyzed the promoter sequences of ANG and identified two CBEs (CBE1 and CBE2) in the ANG promoter region (Fig. 3A) . The promoter activity assay demonstrated that knockdown of COUP-TFII increased ANG promoter activity (Fig. 3B) . To further identify which binding site is important for ANG induction, sitedirected mutagenesis was employed to mutate individual CBEs on the ANG promoter region. The reporter activity was increased when CBE1 was mutated (Fig. 3C ), indicating this is the site that COUP-TFII binds. In contrast, mutating CBE2 did not affect ANG promoter activity, providing evidence to exclude it as the functional COUP-TFII binding site (Fig. 3C) .
Angiogenin is overexpressed in endometriotic stromal cells
To investigate whether ANG is a novel angiogenic factor in endometriosis, we first examined the levels of ANG in endometrial and endometriotic tissues derived from women with endometriosis. The level of ANG mRNA was similar in proliferative and secretory phases ( Supplementary Fig. S1) ; therefore, the data were pooled for analysis. Results showed that both mRNA and protein levels of ANG were upregulated in endometriotic lesions compared to the endometrial counterparts (Fig. 4A) . To further evaluate the potential role of ANG in endometriosis using cultured stromal cells, we then evaluated the expression levels of ANG in eutopic and ectopic stromal cells derived from patients with endometriosis. Both Levels of ANG mRNA and protein were significantly elevated in the endometriotic stromal cells compared to their eutopic endometrial counterpart (Fig. 4B) . We also measured the levels of secreted ANG in culture medium. As shown in Fig. 4C , ectopic endometriotic stromal cells secreted more ANG into the culture medium than eutopic endometrial stromal cells. Functionally, conditioned medium collected from ectopic endometriotic stromal cells induced more tube formation than that from paired eutopic counterpart (Fig. 4D) , which can be abolished by knockdown of ANG in ectopic endometriotic stromal cells (Fig. 4D) . To elucidate the functional association between ANG and angiogenesis in endometriosis, the immunohistochemical staining of ANG and CD31 (the marker for blood vessels) from human endometria and endometriotic tissues were performed. The signal of ANG from endometriotic tissues was stronger than that in normal endometria (Fig. 4E) . In contrast, the signals of CD31 in eutopic and ectopic tissues were similar (Fig. 4E) . Of note, the CD31-positive staining was detected in the angiogeninpositive region in endometriotic lesion (Fig. 4E, lower right panel) , while there was no such colocalization in normal endometria (Fig. 4E , lower left panel).
Hypoxia induces ANG expression through downregulation of COUP-TFII
Since hypoxia induces angiogenesis and knockdown of COUP-TFII leads to upregulation of ANG, we hypothesized that hypoxia may induce ANG expression through suppression of COUP-TFII. To test this hypothesis, an expression vector carrying a COUP-TFII minigene was transiently transfected into eutopic endometrial cells followed by treatment with normoxia or hypoxia for 24 h. The results showed that forced expression of COUP-TFII blocked hypoxia-induced ANG promoter activity (Fig. 5A ) and protein expression (Fig. 5B) . More importantly, we performed ChIP PCR to demonstrate that COUP-TFII indeed bound to the ANG promoter region, and the binding of COUP-TFII can be reduced by hypoxia treatment (Fig. 5C ). Taken together, this result provided evidence to demonstrate that hypoxiainduced upregulation of ANG in eutopic stromal cells is through the suppression of COUP-TFII.
To show whether loss-of-COUP-II-induced ANG is capable of promoting angiogenesis, the conditioned media collected from eutopic stromal cells with COUP-TFII knocked down, or combinational knockdown of COUP-TFII and ANG were used to analyze the angiogenic capacity. Results showed that level of secreted ANG was elevated in conditioned media collected from COUP-TFII knockdown cells but not in the conditioned media collected from COUP-TFII/ANG double knockdown cells (Fig. 6A) . Consequently, HUVECs formed many more loops when treated with conditioned media collected from COUP-TFII knockdown cells compared to control or COUP-TFII/ ANG double knockdown cells (Fig. 6B) . These results demonstrated that loss-of-COUP-TFII-induced angiogenesis in vitro was mediated by ANG.
Next, the conditioned media collected from eutopic stromal cells cultured under normoxia or hypoxia with or without COUP-TFII overexpression were used for the in vitro tube formation assay. Results showed that hypoxia induced ANG in conditioned media, and the hypoxia-induced effect was abolished by overexpression of COUP-TFII (Fig. 6C) . Consistent with level of secreted ANG in conditioned media, the invasion ability and tube formation capacity of HUVECs were markedly increased when treated with conditioned media collected from endometrial stromal cells cultured under hypoxia (Fig. 6D) . Overexpression of COUP-TFII in eutopic stromal cells abolished hypoxia-induced HUVECs invasion and tube formation abilities (Fig. 6E) . These results indicated that downregulation of COUP-TFII is essential for hypoxia-induced angiogenesis via induction of ANG expression.
Discussion
The development of new blood vessels is a prerequisite for the shed endometrial tissues to survive in remote sites of the peritoneal cavity. Even after successful adhesion and implantation, the ectopic endometriotic lesion still needs to maintain a functional vascular network. Therefore, how to recruit new vessel formation and/or retain a valid vascular network is the critical issue for endometriosis development. Herein, we report a novel mechanism that endometriotic cells utilize for angiogenesis under the unfavorable hypoxic microenvironment. Under hypoxia, endometriotic stromal cells produce more ANG, a potent and noncanonical angiogenic factor, by suppressing the transcription repressor, COUP-TFII (Fig. 6F) . To our knowledge, this is the first report to fully characterize a mechanism responsible for hypoxiainduced ANG expression and the pathological function of ANG in endometriosis. In ectopic endometriotic tissues, an elevated HIF-1α level has been noted (Wu et al. 2007a (Wu et al. , 2007b , which controls many genes related to the pathogenesis of endometriosis (Hsiao et al., 2015) . Herein, we add one more important gene, COUP-TFII, to that list. COUP-TFII is an orphan nuclear receptor that normally exerts a suppressive effect in regulating gene expression (Lin et al., 2011b) . COUP-TFII but not COUP-TFI expression is reduced in endometriotic stromal cells, which leads to de-repression of certain critical genes important for cell survival, such as COX-2 and aromatase (Zeitoun et al., 1999) . Previously, we reported that expression of COUP-TFII is inhibited by proinflammatory cytokine-elicited microRNA expression, a mechanism controlled at the post-transcriptional level . Herein, we demonstrate that hypoxia is able to suppress COUP-TFII but not COUP-TFI gene expression, providing another mechanism to regulate COUP-TFII expression in endometriotic stromal cells. Since COUP-TFII is commonly known as a transcription repressor, normal endometrial stromal cells express high levels of COUP-TFII, which keeps the steroidogenic gene aromatase and the proinflammatory gene COX-2 silent (Zeitoun et al., 1999; Lin et al., 2014) to maintain the normal physiological function of uterine endometria. When endometrial tissues shed off from the highly vascularized uterus, they immediately face hypoxic stress. Under such hypoxic stress, they need to express some critical genes to circumvent the stress for survival. De-repression of COX-2 leads to over-production of prostaglandin E 2 , which has been shown to promote steroidogenesis, angiogenesis and anti-apoptosis, and more importantly, to suppress macrophage's phagocytic ability (Tsai et al., 2001; . Samples without positive staining were assigned a score of 0. Scores of 1 and 2 are for weak and strong stain, respectively. *P < 0.05 by Student's t-test (for two groups) or ANOVA followed by Turkey's multiple test (for three or more groups). Arosh et al., 2015) . Thus, by inhibiting a key suppressor, namely COUP-TFII, endometriotic cells simultaneously de-repress several COX-2-mediated survival processes. This is an efficient and energyconserving way for cells to adapt to low energy-producing stress such as nutrient deprivation or hypoxia. Our current data showing that hypoxia suppresses COUP-TFII provide key evidence to explain how ectopic endometriotic cells are able to survive under the hypoxic peritoneal cavity.
COUP-TFII was originally discovered as an orphan nuclear receptor with primary suppressive effects (Bailey et al., 1997; Shibata et al., 1997) . Subsequent studies revealed that COUP-TFII not only can serve as transcriptional repressor, but also exerts a co-activating function in some biological processes, including promoting angiogenesis in cancerous epithelial cells (Qin et al., 2010) and hepatic stellate cells (Ceni et al., 2017) . In contrast, in uterine endometrial stromal cells COUP-TFII was found to suppress steroidogenic capacity by inhibiting StAR and aromatase expression (Zeitoun et al., 1999; Attar et al., 2009) . Our previous study also showed that COUP-TFII suppresses COX-2 expression in endometrial stromal cells and loss of COUP-TFII results in de-repression of COX-2 in endometriotic stromal cells . Herein, we demonstrate that COUP-TFII binds to the ANG promoter to suppress its expression under normoxia, and downregulation of COUP-TFII by hypoxia promotes ANG expression and angiogenesis. Our finding that COUP-TFII suppresses angiogenesis is not unprecedented since it was also reported that COUP-TFII binds to VEGF receptor 2 to suppress its expression in lymphatic endothelial cells (Kang et al., 2010) . Therefore, it is likely that COUP-TFII can act as a transcription repressor or activator in a cell type-and gene-specific manner. Whether the distinct functions of COUP-TFII are determined by the promoter context or transcriptional partners remains an open question. Alternatively, an unidentified ligand may also play some roles in directing the biological function of COUP-TFII. Further studies to identify the binding partners or an unidentified ligand of COUP-TFII are warranted and the results should help us to clarify further the actions of COUP-TFII in physiological and pathological processes.
Hypoxia is an indispensable regulator for promoting angiogenesis. However, a great number of angiogenesis-related genes are not direct targets of HIFs due to lack of typical hypoxia responsive elements in the promoter of these genes. In the present study we provided evidence to demonstrate that COUP-TFII may be a critical link between hypoxia and angiogenic factors in endometriosis. ANG is a potent angiogenic factor originally identified from the conditioned media of human colon adenocarcinoma cells, HT-29 . Although previous studies reported that upregulation of ANG is correlated to hypoxia in cancer cells and motor neurons (Hartmann et al., 1999; Sebastia et al., 2009; Kishimoto et al., 2012) , the underlying molecular mechanism remains unresolved. Besides, no hypoxia response element in the ANG promoter was found, indicating it is not a direct target of HIF-1α or HIF-2α. By employing microarray experiments and bioinformatic analysis, we identified ANG as a novel target gene regulated by COUP-TFII. Intriguingly, although elevation of ANG was previously found in the mid and late secretory phases of normal endometria (Koga et al., 2001) and in peritoneal fluid of women with endometriosis (Suzumori et al., 2004) , the regulation and clinical implication of ANG in endometriosis had never been addressed. Here we provide evidence to demonstrate that hypoxia-suppressed COUP-TFII expression is the critical factor in causing ANG upregulation in endometriotic stromal cells. Our data show that hypoxia treatment reduces COUP-TFII binding to the ANG promoter and concomitantly causes ANG upregulation. In contrast, overexpression of COUP-TFII abolishes hypoxia-induced ANG expression. These results provide direct evidence to demonstrate that hypoxia-induced ANG expression is (at least in part) through suppression of COUP-TFII in endometriosis.
ANG is a potent angiogenic factor with unique features compared to VEGFs (Lyons et al., 2017) . It has been shown that angiogenic deficiency induced by loss of ANG cannot be rescued by administration of VEGF (Kishimoto et al., 2005) , suggesting that ANG is a pivotal controller for angiogenesis. Sequence analysis of ANG revealed a 35% amino acid similarity with ribonuclease (RNase) A , thus, it was also named RNase 5. ANG exerts very weak RNase activity, which is required for its angiogenic activity (Shapiro and Vallee, 1989) . Nonetheless, how ANG exerts its angiogenic activity remains unknown. When ANG reaches target cells, it is internalized to the cytoplasm and translocates to the nucleus where it exerts Lower panel shows the quantitative results of ChIP from eutopic stromal cells treated with normoxia (N) or hypoxia (H) (n = 4). NC: ChIP assay performed with normal mouse IgG. *P < 0.05 by Student's t-test (for two groups) or ANOVA followed by Turkey's multiple test (for three or more groups). distinct functions (Li et al., 1997) . However, the receptor/protein that mediates ANG internalization is still not fully characterized. It has been suggested that Syndecan-4 (Skorupa et al., 2012) , a~170 kDa protein, and a~49 kDa protein could be the mediators for ANG internalization but experimental verification is needed to draw a firm conclusion. Regardless of the many unresolved questions, upregulation of ANG in various cancers is associated with tumor angiogenesis (Chopra et al., 1997; Montero et al., 1998; Shimoyama et al., 2002; Yoshioka et al., 2006; Miyake et al., 2015) . In this study, we demonstrate that ANG is secreted into conditioned media in hypoxia-treated or COUP-TFII knockdown endometrial stromal cells. Knockdown of ANG in stromal cells abolishes hypoxia-and loss-of-COUP-TFIIinduced in vitro angiogenesis. These data show, for the first time, that ANG is a bona fide angiogenic factor secreted by endometriotic cells. Five batches of conditioned media collected from different endometrial stromal cells treated as described were used to treat HUVECs. (F) Hypoxia-mediated COUP-TFII downregulation promotes angiogenesis in endometriosis. *P < 0.05 by ANOVA followed by Turkey's multiple test.
In conclusion, our study presented a novel relationship linking hypoxia, COUP-TFII and ANG-mediated angiogenesis, which provides a fundamental framework for unraveling the molecular pathogenesis of endometriosis.
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